Stokes Family Office LLC Has $1.69 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Stokes Family Office LLC raised its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 27.2% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,421 shares of the healthcare conglomerate’s stock after purchasing an additional 731 shares during the quarter. Stokes Family Office LLC’s holdings in UnitedHealth Group were worth $1,692,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of UNH. Vanguard Group Inc. increased its position in UnitedHealth Group by 0.3% during the 4th quarter. Vanguard Group Inc. now owns 83,860,515 shares of the healthcare conglomerate’s stock worth $44,150,045,000 after buying an additional 250,291 shares during the period. Wellington Management Group LLP raised its stake in UnitedHealth Group by 2.1% in the 3rd quarter. Wellington Management Group LLP now owns 25,220,234 shares of the healthcare conglomerate’s stock worth $12,715,790,000 after purchasing an additional 527,526 shares in the last quarter. Capital Research Global Investors grew its position in shares of UnitedHealth Group by 2.2% during the 4th quarter. Capital Research Global Investors now owns 15,122,203 shares of the healthcare conglomerate’s stock worth $7,961,369,000 after purchasing an additional 324,733 shares in the last quarter. Capital International Investors raised its position in shares of UnitedHealth Group by 4.8% in the fourth quarter. Capital International Investors now owns 11,860,985 shares of the healthcare conglomerate’s stock valued at $6,244,158,000 after buying an additional 542,424 shares in the last quarter. Finally, Norges Bank acquired a new stake in UnitedHealth Group during the fourth quarter worth approximately $5,802,231,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Up 1.4 %

UnitedHealth Group stock traded up $7.17 during trading hours on Friday, hitting $511.53. 3,532,475 shares of the stock traded hands, compared to its average volume of 4,236,860. The company has a market cap of $470.81 billion, a PE ratio of 30.93, a PEG ratio of 1.47 and a beta of 0.60. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.69. The firm’s 50-day moving average price is $499.20 and its two-hundred day moving average price is $500.05. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $554.70.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.63 by $0.28. The company had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. UnitedHealth Group’s quarterly revenue was up 8.6% compared to the same quarter last year. During the same period last year, the business earned $6.26 EPS. On average, research analysts forecast that UnitedHealth Group Incorporated will post 27.55 EPS for the current year.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 25th. Investors of record on Monday, June 17th were issued a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.64%. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.88. The ex-dividend date of this dividend was Monday, June 17th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 51.34%.

Analyst Ratings Changes

Several analysts have recently issued reports on UNH shares. Robert W. Baird assumed coverage on UnitedHealth Group in a report on Thursday, May 30th. They set an “outperform” rating and a $597.00 target price on the stock. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Wednesday. JPMorgan Chase & Co. upped their target price on UnitedHealth Group from $546.00 to $559.00 and gave the stock an “overweight” rating in a report on Thursday, May 30th. TD Cowen lowered their price objective on UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating for the company in a research note on Wednesday, April 10th. Finally, Morgan Stanley reduced their target price on shares of UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating on the stock in a report on Friday, April 5th. Two equities research analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $581.44.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.